A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned

NCT00191750 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Small Cell

Interventions

DRUG: Pemetrexed

Sponsor

Eli Lilly and Company